• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表观遗传模式的遗传决定因素:洞察疾病

Genetic Determinants of Epigenetic Patterns: Providing Insight into Disease.

作者信息

Cazaly Emma, Charlesworth Jac, Dickinson Joanne L, Holloway Adele F

机构信息

Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.

School of Medicine, University of Tasmania, Hobart, Tasmania, Australia.

出版信息

Mol Med. 2015 Mar 26;21(1):400-9. doi: 10.2119/molmed.2015.00001.

DOI:10.2119/molmed.2015.00001
PMID:25822796
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4559532/
Abstract

The field of epigenetics and our understanding of the mechanisms that regulate the establishment, maintenance and heritability of epigenetic patterns continue to grow at a remarkable rate. This information is providing increased understanding of the role of epigenetic changes in disease, insight into the underlying causes of these epigenetic changes and revealing new avenues for therapeutic intervention. Epigenetic modifiers are increasingly being pursued as therapeutic targets in a range of diseases, with a number of agents targeting epigenetic modifications already proving effective in diseases such as cancer. Although it is well established that DNA mutations and aberrant expression of epigenetic modifiers play a key role in disease, attention is now turning to the interplay between genetic and epigenetic factors in complex disease etiology. The role of genetic variability in determining epigenetic profiles, which can then be modified by environmental and stochastic factors, is becoming more apparent. Understanding the interplay between genetic and epigenetic factors is likely to aid in identifying individuals most likely to benefit from epigenetic therapies. This goal is coming closer to realization because of continual advances in laboratory and statistical tools enabling improvements in the integration of genomic, epigenomic and phenotypic data.

摘要

表观遗传学领域以及我们对调控表观遗传模式的建立、维持和遗传性机制的理解,正继续以惊人的速度发展。这些信息使我们对表观遗传变化在疾病中的作用有了更多了解,深入洞察了这些表观遗传变化的潜在原因,并揭示了治疗干预的新途径。表观遗传修饰剂正越来越多地被作为多种疾病的治疗靶点进行研究,一些针对表观遗传修饰的药物已在癌症等疾病中证明有效。虽然DNA突变和表观遗传修饰剂的异常表达在疾病中起关键作用已得到充分证实,但现在人们的注意力正转向复杂疾病病因中遗传和表观遗传因素之间的相互作用。遗传变异性在决定表观遗传谱方面的作用正变得更加明显,而后表观遗传谱可被环境和随机因素所改变。理解遗传和表观遗传因素之间的相互作用可能有助于识别最有可能从表观遗传疗法中获益的个体。由于实验室和统计工具的不断进步,能够改进基因组、表观基因组和表型数据的整合,这一目标正越来越接近实现。

相似文献

1
Genetic Determinants of Epigenetic Patterns: Providing Insight into Disease.表观遗传模式的遗传决定因素:洞察疾病
Mol Med. 2015 Mar 26;21(1):400-9. doi: 10.2119/molmed.2015.00001.
2
Epigenetic modifications in multiple myeloma: recent advances on the role of DNA and histone methylation.多发性骨髓瘤中的表观遗传修饰:DNA和组蛋白甲基化作用的最新进展
Expert Opin Ther Targets. 2017 Jan;21(1):91-101. doi: 10.1080/14728222.2016.1266339.
3
Epigenomics and the regulation of aging.表观基因组学与衰老调控。
Epigenomics. 2013 Apr;5(2):205-27. doi: 10.2217/epi.13.5.
4
Epigenetic mechanisms in Parkinson's disease.帕金森病中的表观遗传机制。
J Neurol Sci. 2015 Feb 15;349(1-2):3-9. doi: 10.1016/j.jns.2014.12.017. Epub 2014 Dec 18.
5
Regulatory roles of epigenetic modulators, modifiers and mediators in lung cancer.表观遗传修饰物、修饰剂和介质在肺癌中的调控作用。
Semin Cancer Biol. 2017 Feb;42:4-12. doi: 10.1016/j.semcancer.2016.11.007. Epub 2016 Nov 10.
6
Cardiovascular diseases: Interplay of epigenetics.心血管疾病:表观遗传学的相互作用。
Clin Exp Hypertens. 2017;39(1):1-7. doi: 10.1080/10641963.2016.1210627. Epub 2017 Jan 5.
7
Epigenetic chromatin modifications in Brassica genomes.芸薹属基因组中的表观遗传染色质修饰。
Genome. 2010 Mar;53(3):203-10. doi: 10.1139/g09-088.
8
The evolving epigenome.不断变化的表观基因组。
Hum Mol Genet. 2013 Oct 15;22(R1):R1-6. doi: 10.1093/hmg/ddt348. Epub 2013 Jul 29.
9
Epigenetics and pharmacology.表观遗传学与药理学。
Br J Pharmacol. 2015 Jun;172(11):2701-4. doi: 10.1111/bph.13136.
10
Epitranscriptomics and epigenetics: two sides of the same coin?转录组学和表观遗传学:同一枚硬币的两面?
Clin Epigenetics. 2024 Sep 3;16(1):121. doi: 10.1186/s13148-024-01729-4.

引用本文的文献

1
Cross-omics risk scores of inflammation markers are associated with all-cause mortality: The Canadian Longitudinal Study on Aging.炎症标志物的跨组学风险评分与全因死亡率相关:加拿大衰老纵向研究。
Am J Hum Genet. 2025 Aug 7;112(8):1892-1905. doi: 10.1016/j.ajhg.2025.06.009. Epub 2025 Jul 8.
2
Impact of Wood Smoke Exposure on Aortic Valve Mineralization: Microvesicles as Mineral Conveyors in Patients with Coronary Stenosis.接触木烟对主动脉瓣矿化的影响:微泡作为冠状动脉狭窄患者矿物质的输送载体
J Clin Med. 2024 Dec 30;14(1):146. doi: 10.3390/jcm14010146.
3
The Role of Histone Acetylation-/Methylation-Mediated Apoptotic Gene Regulation in Hepatocellular Carcinoma.组蛋白乙酰化/甲基化介导的凋亡基因调控在肝细胞癌中的作用。
Int J Mol Sci. 2020 Nov 24;21(23):8894. doi: 10.3390/ijms21238894.
4
Influence of Genotype and T3111C Interaction with Cardiovascular Risk Factors on the Progression to Alzheimer's Disease in Subjective Cognitive Decline and Mild Cognitive Impairment Patients.基因型及T3111C与心血管危险因素的相互作用对主观认知衰退和轻度认知障碍患者进展为阿尔茨海默病的影响。
J Pers Med. 2020 May 29;10(2):45. doi: 10.3390/jpm10020045.
5
The Effect of Long Non-Coding RNA (lncRNA) HCP5 on Regulating Epithelial-Mesenchymal Transition (EMT)-Related Markers in Gastric Carcinoma Is Partially Reversed by miR-27b-3p.长链非编码 RNA (lncRNA) HCP5 对胃癌上皮-间质转化(EMT)相关标志物的调节作用部分被 miR-27b-3p 逆转。
Med Sci Monit. 2020 May 1;26:e921383. doi: 10.12659/MSM.921383.
6
CLOCK gene polymorphisms and quality of aging in a cohort of nonagenarians - The MUGELLO Study.时钟基因多态性与 90 岁以上队列的衰老质量 - MUGELLO 研究。
Sci Rep. 2019 Feb 6;9(1):1472. doi: 10.1038/s41598-018-37992-8.
7
Antibody drug conjugates (ADCs) charged with HDAC inhibitor for targeted epigenetic modulation.负载组蛋白去乙酰化酶抑制剂用于靶向表观遗传调控的抗体药物偶联物(ADCs)。
Chem Sci. 2018 Jul 3;9(31):6490-6496. doi: 10.1039/c7sc05266a. eCollection 2018 Aug 21.
8
Exome sequencing study in patients with multiple sclerosis reveals variants associated with disease course.外显子组测序研究多发性硬化症患者揭示了与疾病进程相关的变异。
J Neuroinflammation. 2018 Sep 14;15(1):265. doi: 10.1186/s12974-018-1307-1.
9
The role of epigenomics in personalized medicine.表观基因组学在个性化医疗中的作用。
Expert Rev Precis Med Drug Dev. 2017;2(1):33-45. doi: 10.1080/23808993.2017.1284557. Epub 2017 Jan 31.

本文引用的文献

1
Human transgenerational responses to early-life experience: potential impact on development, health and biomedical research.人类对早期生活经历的跨代反应:对发育、健康和生物医学研究的潜在影响。
J Med Genet. 2014 Sep;51(9):563-72. doi: 10.1136/jmedgenet-2014-102577. Epub 2014 Jul 25.
2
Epigenetic regulation by heritable RNA.可遗传RNA的表观遗传调控。
PLoS Genet. 2014 Apr 17;10(4):e1004296. doi: 10.1371/journal.pgen.1004296. eCollection 2014 Apr.
3
Epigenetic stochasticity, nuclear structure and cancer: the implications for medicine.表观遗传随机性、核结构与癌症:对医学的启示。
J Intern Med. 2014 Jul;276(1):5-11. doi: 10.1111/joim.12224.
4
Rett syndrome and MeCP2.雷特综合征与 MeCP2。
Neuromolecular Med. 2014 Jun;16(2):231-64. doi: 10.1007/s12017-014-8295-9. Epub 2014 Mar 11.
5
Dawning of the epigenetic era in hereditary cancer.遗传性癌症中表观遗传时代的曙光。
Clin Genet. 2014 May;85(5):413-6. doi: 10.1111/cge.12369.
6
IGF2 DMR0 methylation, loss of imprinting, and patient prognosis in esophageal squamous cell carcinoma.胰岛素样生长因子2差异甲基化区域0甲基化、印记缺失与食管鳞状细胞癌患者预后
Ann Surg Oncol. 2014 Apr;21(4):1166-74. doi: 10.1245/s10434-013-3414-7. Epub 2013 Dec 7.
7
Genetics. Genetics driving epigenetics.遗传学。驱动表观遗传学的遗传学。
Science. 2013 Nov 8;342(6159):705-6. doi: 10.1126/science.1246755.
8
Identification of genetic variants that affect histone modifications in human cells.鉴定影响人类细胞组蛋白修饰的遗传变异。
Science. 2013 Nov 8;342(6159):747-9. doi: 10.1126/science.1242429. Epub 2013 Oct 17.
9
Extensive variation in chromatin states across humans.人类染色质状态的广泛变异。
Science. 2013 Nov 8;342(6159):750-2. doi: 10.1126/science.1242510. Epub 2013 Oct 17.
10
Coordinated effects of sequence variation on DNA binding, chromatin structure, and transcription.序列变异对 DNA 结合、染色质结构和转录的协调影响。
Science. 2013 Nov 8;342(6159):744-7. doi: 10.1126/science.1242463. Epub 2013 Oct 17.